These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Genome-wide analysis for loss of heterozygosity in primary and recurrent phyllodes tumor and fibroadenoma of breast using single nucleotide polymorphism arrays. Wang ZC, Buraimoh A, Iglehart JD, Richardson AL. Breast Cancer Res Treat; 2006 Jun; 97(3):301-9. PubMed ID: 16791486 [Abstract] [Full Text] [Related]
27. Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast. Sapino A, Bosco M, Cassoni P, Castellano I, Arisio R, Cserni G, Dei Tos AP, Fortunati N, Catalano MG, Bussolati G. Mod Pathol; 2006 Apr; 19(4):599-606. PubMed ID: 16554735 [Abstract] [Full Text] [Related]
29. Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors. Abe M, Miyata S, Nishimura S, Iijima K, Makita M, Akiyama F, Iwase T. Breast Cancer; 2011 Oct; 18(4):268-72. PubMed ID: 22121516 [Abstract] [Full Text] [Related]
30. Differential cytologic features of fibroepithelial lesions of the breast. Deen SA, McKee GT, Kissin MW. Diagn Cytopathol; 1999 Feb; 20(2):53-6. PubMed ID: 9951596 [Abstract] [Full Text] [Related]
32. Diagnostic stromal histomorphology in fibroepithelial breast lesions: a fresh perspective. Aiyer HM, Jain M, Thomas S, Logani KB. Indian J Pathol Microbiol; 2000 Jan; 43(1):5-12. PubMed ID: 12583412 [Abstract] [Full Text] [Related]